Skip to content

Haley Maria Dourron

9 papers in the library · 119 citations · publishing 2022-2026

Papers

Sort Most recent Most cited

Do Psychedelics Mimic Psychosis? Perspectives on Similarities and Differences from Individuals with Lived Experience of Psychosis and Psychedelics

International Journal of Mental Health and Addiction March 17, 2026 Haley Maria Dourron, Melissa Bradley, Heith Copes et al.

Abstract Despite a long-standing interest in the potential similarities between psychedelic and psychotic experiences, no recent research has systematically explored the subjective overlap between these states in individuals who have experienced both. To provide rich accounts of potential overlaps and distinctions, we conducted semi-structured interviews with 19 individuals diagnosed with...

How do psychedelics impact people with a history of non-affective psychosis? A qualitative study.

Front Psychiatry December 9, 2025 Haley Maria Dourron, Heith Copes, Daniel H. Grossman et al. 3 citations

Background: People with a history of psychotic disorders are excluded from contemporary trials of psychedelic-assisted therapy. Although survey studies have explored the impact of naturalistic psychedelic use on people with a history of psychotic disorders, a qualitative study has yet to examine the subjective effects of psychedelic use in this population during both the acute effects and...

Naturalistic Psychedelic Use and Psychotic Symptoms: A Cross-Sectional Study of Individuals with a Personal or Family History of Psychotic or Bipolar Disorders.

Psychedelic medicine (New Rochelle, N.Y.) June 1, 2025 Haley Maria Dourron, Melissa Bradley, Otto Simonsson et al. 7 citations

Prior research examining the associations between psychedelic use and general psychotic symptoms has yielded mixed findings. However, no studies have investigated the relationships between psychedelic use and specific psychotic symptoms, and whether these relationships might differ among those with liability to psychosis, namely those with a history of psychotic or bipolar disorders. Using...

Psychedelics' Uncertain Risks: A Reply to Myran et al.

November 22, 2024 Haley Maria Dourron, Melissa Bradley, Peter S. Hendricks 1 citation preprint

Myran et al. report that emergency room (ER) visits involving hallucinogens are associated with a 21.32 greater risk of being diagnosed with a schizophrenia spectrum disorder (SSD).1 Although implications for the development of psychedelics as medicines are discussed, we highlight some important distinctions.

Longitudinal associations between psychedelic use and psychotic symptoms in the United States and the United Kingdom

Journal of Affective Disorders January 26, 2024 Ludwig Honk, Cecilia U.D. Stenfors, Simon B. Goldberg et al. 41 citations

It has long been speculated that psychedelic use could provoke the onset of psychosis, but there is little evidence to support this conjecture. Using a longitudinal research design with samples representative of the US and UK adult populations with regard to sex, age, and ethnicity (n = 9732), we investigated associations between psychedelic use and change in the number of psychotic symptoms...

Exploring the Unique Therapeutic Potential of Psychedelics to Reduce Chronic Shame Among Sexual and Gender Minority Adults.

Psychedelic Med (New Rochelle) December 13, 2023 Nicholas A. Carlisle, Haley Maria Dourron, Sarah Maccarthy et al. 12 citations

Exploring the Unique Therapeutic Potential of Psychedelics to Reduce Chronic Shame Among Sexual and Gender Minority Adults.

5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk?

Psychopharmacology December 11, 2023 Haley Maria Dourron, Charles D. Nichols, Otto Simonsson et al. 23 citations

5-MeO-DMT is a tryptamine being developed as a potential antidepressant that may display a distinct therapeutic mechanism due to its unique pharmacology and subjective effects compared to typical psychedelics. In this article, we parallel the relatively distinct phenomenology and behavioral effects of the acute and post-acute effects of 5-MeO-DMT to those induced by epileptiform activity,...

A Qualitative Analysis of First-Hand Accounts of Diphenhydramine Misuse Available on YouTube

Journal of Psychoactive Drugs August 31, 2023 Haley Maria Dourron, Heith Copes, Agasthya Vedre-Kyanam et al. 6 citations

Deliriants are the least studied class of hallucinogens and display noticeable subjective effects, including dysphoria, hallucinations, and substantial alterations in thought. High doses of diphenhydramine (DPH), an over-the-counter antihistamine medication, can produce deliriant effects due to secondary anticholinergic activity. We sought to characterize the subjective experiences produced by...

Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations

Neuropharmacology May 13, 2022 Cynthia E. Ortiz, Haley Maria Dourron, Noah W Sweat et al. 26 citations

Psilocybin-facilitated psychotherapy shows potential transdiagnostic efficacy for a range of mental health conditions. Though vulnerable populations bear disproportionate mental health burden, they have been largely neglected in the clinical psilocybin literature. However, if the field is to best respond to the diverse needs of individuals from vulnerable populations, care must be taken to...